CODX vs. ICU, LNSR, ICAD, MODD, CTCX, XAIR, GBS, RVP, AKLI, and MDAI
Should you be buying Co-Diagnostics stock or one of its competitors? The main competitors of Co-Diagnostics include SeaStar Medical (ICU), LENSAR (LNSR), iCAD (ICAD), Modular Medical (MODD), Carmell (CTCX), Beyond Air (XAIR), GBS (GBS), Retractable Technologies (RVP), Akili (AKLI), and Spectral AI (MDAI). These companies are all part of the "surgical & medical instruments" industry.
Co-Diagnostics (NASDAQ:CODX) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, community ranking, valuation, dividends and media sentiment.
Co-Diagnostics has a beta of -0.65, indicating that its share price is 165% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -0.96, indicating that its share price is 196% less volatile than the S&P 500.
Co-Diagnostics received 272 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 63.49% of users gave Co-Diagnostics an outperform vote.
Co-Diagnostics presently has a consensus price target of $2.50, indicating a potential upside of 104.92%. Given Co-Diagnostics' higher possible upside, research analysts clearly believe Co-Diagnostics is more favorable than SeaStar Medical.
SeaStar Medical has a net margin of 0.00% compared to Co-Diagnostics' net margin of -518.69%. SeaStar Medical's return on equity of 0.00% beat Co-Diagnostics' return on equity.
SeaStar Medical has lower revenue, but higher earnings than Co-Diagnostics. Co-Diagnostics is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, SeaStar Medical had 2 more articles in the media than Co-Diagnostics. MarketBeat recorded 2 mentions for SeaStar Medical and 0 mentions for Co-Diagnostics. Co-Diagnostics' average media sentiment score of 0.00 beat SeaStar Medical's score of -0.04 indicating that Co-Diagnostics is being referred to more favorably in the media.
15.0% of Co-Diagnostics shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 2.4% of Co-Diagnostics shares are owned by insiders. Comparatively, 4.5% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
SeaStar Medical beats Co-Diagnostics on 8 of the 15 factors compared between the two stocks.
Get Co-Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CODX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Co-Diagnostics Competitors List
Related Companies and Tools
